FindTrial
Sign In

Myocardial Protection with Glucose-Insulin-Potassium (GIK) in Patients Undergoing Percutaneous Coronary Interventions

Myocardial Protection with Glucose-Insulin-Potassium (GIK) in Patients Undergoing Percutaneous Coronary Interventions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-05000653
Enrollment
Unknown
Registered
2005-09-09
Start date
2003-03-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart and Blood Vessel Diseases

Interventions

Two groups:Glucose-Insulin-Potassium during Percutaneous Coronary Intervention (PCI) for few hours versus placebo

Sponsors

NONE
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients undergoing elective PCI with normal, static or decreasing level of troponin levl

Exclusion criteria

Exclusion criteria: Exclusion Patients undergoing direct PCI for ST elevation myocardial infarction Patients on regular insuli therapy Patients with uncorrected hypokalaemia, hyperkalaemia, hypoglycemia or hyperglycemia Patients with rising level of troponin Patients with creatine level > 250

Design outcomes

Primary

MeasureTime frame
Troponin rise after PCI;—

Secondary

MeasureTime frame
Composite endpoint of 30 days major cardiovascular events post PCI;—

Countries

China

Contacts

Public ContactChan Yat Sun Joseph
jyschan@cuhk.edu.hkNil

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026